logo

SIGACHI vs WOCKPHARMA: Stock Comparison

SIGACHI INDUSTRIES vs WOCKHARDTUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. SIGACHI INDUSTRIES shows a lower P/E, a higher dividend yield and lower leverage, while WOCKHARDT shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SIGACHI leads 4; WOCKPHARMA leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SIGACHIWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹989 Cr
₹30,126 Cr
P/E RatioSIGACHI has the lower reading
39.23x ✓
73.66x
P/B RatioSIGACHI has the lower reading
1.9x ✓
6.1x
EPSWOCKPHARMA has the higher reading
₹0.18
₹6.52 ✓
Book ValueContext only
₹13.84
₹325
Dividend YieldSIGACHI has the higher reading
0.38% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹30,126 Cr vs ₹989 Cr
P/E Ratio
SIGACHI has a lower P/E
39.23x vs 73.66x
P/B Ratio
SIGACHI has a lower P/B
1.9x vs 6.1x
EPS
WOCKPHARMA has higher earnings per share
₹6.52 vs ₹0.18
Dividend Yield
SIGACHI has a higher dividend yield
0.38% vs 0%
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs 16.22%
ROE
WOCKPHARMA has a higher ROE
3.77% vs -16.71%
ROCE
WOCKPHARMA has a higher ROCE
5.44% vs -13.23%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSIGACHIWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricSIGACHIWOCKPHARMA
Live Price₹25.95₹1,855.5
Day Change-0.65%-1.16%
Volume10.42 L4.57 L
52-Week High₹40.8₹2,422.3
52-Week Low₹16.65₹1,086.7
Distance from 52W High-36.4%-23.4%

Valuation

MetricSIGACHIWOCKPHARMA
Market Cap₹989 Cr₹30,126 Cr
P/E Ratio39.23x73.66x
P/B Ratio1.9x6.1x
EPS₹0.18₹6.52
Book Value₹13.84₹325
Dividend Yield0.38%0%

Growth

MetricSIGACHIWOCKPHARMA
Revenue Growth (TTM YoY)16.22%26%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricSIGACHIWOCKPHARMA
ROE-16.71%3.77%
ROCE-13.23%5.44%
Net Margin-17.33%3.3%
Operating Margin-19.63%13.37%
Debt to Equity0.21x0.4x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSIGACHIWOCKPHARMA
Promoter Holding36.69%49.08%
FII Holding1.25%▼ 0.05 pp7.22%▲ 0.13 pp
DII Holding0%9.24%▼ 1.72 pp
Public Holding62.05%▲ 0.04 pp34.44%▲ 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SIGACHI INDUSTRIES and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.